A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. (Q64679433)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. |
clinical trial |
Statements
CHEST-1 (English)
0 references
Randomized, Double-blind, Placebo-controlled, Multi-centre, Multi-national Study to Evaluate the Efficacy and Safety of Oral BAY63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (English)
0 references
February 2009
0 references
June 2012
0 references
262
0 references
18 year
0 references
80 year
0 references